David Roth

9.2k total citations · 1 hit paper
178 papers, 6.2k citations indexed

About

David Roth is a scholar working on Transplantation, Surgery and Hepatology. According to data from OpenAlex, David Roth has authored 178 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Transplantation, 60 papers in Surgery and 49 papers in Hepatology. Recurrent topics in David Roth's work include Renal Transplantation Outcomes and Treatments (101 papers), Hepatitis C virus research (45 papers) and Organ Transplantation Techniques and Outcomes (37 papers). David Roth is often cited by papers focused on Renal Transplantation Outcomes and Treatments (101 papers), Hepatitis C virus research (45 papers) and Organ Transplantation Techniques and Outcomes (37 papers). David Roth collaborates with scholars based in United States, Canada and Sweden. David Roth's co-authors include George W. Burke, Gaetano Ciancio, Joshua Miller, Warren Kupin, Jeffrey J. Gaynor, Anne Rosén, Violet Esquenazi, Adela Mattiazzi, Phillip Ruiz and Giselle Guerra and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

David Roth

177 papers receiving 6.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4–5 chronic kidney disease (the C-SURFER study): a combination phase 3 study

2015 477 citations David Roth, David R. Nelson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Roth United States	44	2.9k	1.8k	1.6k	1.5k	991	178	6.2k
Roy D. Bloom United States	48	3.2k 1.1×	2.2k 1.2×	1.6k 1.0×	1.3k 0.9×	746 0.8×	171	6.3k
George W. Burke United States	48	3.5k 1.2×	3.2k 1.7×	938 0.6×	1.1k 0.8×	1.2k 1.2×	293	7.4k
Suphamai Bunnapradist United States	51	3.9k 1.4×	2.8k 1.5×	1.1k 0.7×	1.5k 1.0×	1.1k 1.1×	208	6.9k
William Irish United States	45	3.0k 1.1×	3.7k 2.0×	1.8k 1.2×	1.8k 1.2×	379 0.4×	190	8.0k
Niraj M. Desai United States	47	2.4k 0.8×	3.1k 1.7×	1.6k 1.0×	867 0.6×	1.1k 1.1×	129	6.4k
Ronald M. Ferguson United States	47	3.1k 1.1×	2.4k 1.3×	574 0.4×	1.1k 0.7×	533 0.5×	149	6.0k
Gaetano Ciancio United States	44	3.0k 1.0×	3.2k 1.7×	718 0.5×	785 0.5×	872 0.9×	363	7.2k
Jayme E. Locke United States	37	2.8k 1.0×	2.4k 1.3×	1.1k 0.7×	842 0.6×	703 0.7×	200	5.0k
Brian J. Nankivell Australia	39	4.5k 1.6×	2.8k 1.6×	451 0.3×	785 0.5×	1.4k 1.4×	103	6.9k
Thomas A. Gonwa United States	49	3.3k 1.2×	4.9k 2.7×	4.1k 2.6×	2.2k 1.4×	569 0.6×	173	8.1k

Countries citing papers authored by David Roth

Since Specialization

Citations

This map shows the geographic impact of David Roth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Roth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Roth more than expected).

Fields of papers citing papers by David Roth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Roth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Roth. The network helps show where David Roth may publish in the future.

Co-authorship network of co-authors of David Roth

This figure shows the co-authorship network connecting the top 25 collaborators of David Roth. A scholar is included among the top collaborators of David Roth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Roth. David Roth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Burke, George W., Alla Mitrofanova, Gaetano Ciancio, et al.. (2023). The podocyte: glomerular sentinel at the crossroads of innate and adaptive immunity. Frontiers in Immunology. 14. 1201619–1201619. 10 indexed citations

Gaynor, Jeffrey J., Nestor de la Cruz‐Muñoz, Junichiro Sageshima, et al.. (2018). Roux‐en‐Y gastric bypass is an effective bridge to kidney transplantation: Results from a single center. Clinical Transplantation. 32(5). e13232–e13232. 21 indexed citations

Reddy, K. Rajender, David Roth, Annette Bruchfeld, et al.. (2017). Elbasvir/grazoprevir does not worsen renal function in patients with hepatitis C virus infection and pre‐existing renal disease. Hepatology Research. 47(12). 1340–1345. 18 indexed citations

Bruchfeld, Annette, David Roth, Paul Martin, et al.. (2017). Elbasvir plus grazoprevir in patients with hepatitis C virus infection and stage 4–5 chronic kidney disease: clinical, virological, and health-related quality-of-life outcomes from a phase 3, multicentre, randomised, double-blind, placebo-controlled trial. The Lancet. Gastroenterology & hepatology. 2(8). 585–594. 53 indexed citations

Gaynor, Jeffrey J., Gaetano Ciancio, Giselle Guerra, et al.. (2014). Single-centre study of 628 adult, primary kidney transplant recipients showing no unfavourable effect of new-onset diabetes after transplant. Diabetologia. 58(2). 334–345. 24 indexed citations

Isakova, Tamara, Hua-Tao Xie, Shari Messinger, et al.. (2012). Inhibitors of mTOR and Risks of Allograft Failure and Mortality in Kidney Transplantation. American Journal of Transplantation. 13(1). 100–110. 42 indexed citations

Morales, José, Roy D. Bloom, & David Roth. (2012). Kidney Transplantation in the Patient with Hepatitis C Virus Infection. Contributions to nephrology. 176. 77–86. 21 indexed citations

Roth, David & Roy D. Bloom. (2012). Selection and Management of Hepatitis C Virus-Infected Patients for the Kidney Transplant Waiting List. Contributions to nephrology. 176. 66–76. 10 indexed citations

Cortazar, Frank B., Miklos Z. Molnar, Tamara Isakova, et al.. (2011). Clinical Outcomes in Kidney Transplant Recipients Receiving Long-Term Therapy With Inhibitors of the Mammalian Target of Rapamycin. American Journal of Transplantation. 12(2). 379–387. 27 indexed citations

10.

Morshed, Muhammad, Patrick Tang, Martin Petric, et al.. (2010). West Nile Virus Finally Debuts in British Columbia 10 Years After Its Introduction to North America. Vector-Borne and Zoonotic Diseases. 11(8). 1221–1224. 2 indexed citations

11.

Ciancio, Gaetano, Jeffrey J. Gaynor, David Roth, et al.. (2010). Randomized Trial of Thymoglobulin Versus Alemtuzumab (with Lower Dose Maintenance Immunosuppression) Versus Daclizumab in Living Donor Renal Transplantation. Transplantation Proceedings. 42(9). 3503–3506. 33 indexed citations

12.

Sfakianakis, George N., Efrosyni Sfakianaki, Aldo N. Serafini, et al.. (2009). A Renal Protocol for All Ages and All Indications: Mercapto-Acetyl-Triglycine (MAG3) With Simultaneous Injection of Furosemide (MAG3-F0): A 17-Year Experience. Seminars in Nuclear Medicine. 39(3). 156–173. 21 indexed citations

13.

Merrill, Donna, et al.. (2004). Nephrology nurses in a new role: diagnostic and interventional nephrology.. PubMed. 31(4). 390, 395–6. 1 indexed citations

14.

Banerjee, Debasish, Warren Kupin, & David Roth. (2003). Hemolytic uremic syndrome after multivisceral transplantation treated with intravenous immunoglobulin. Journal of Nephrology. 16(5). 733–735. 12 indexed citations

15.

Ciancio, Gaetano, George W. Burke, Kiliana Suzart‐Woischnik, et al.. (2002). Effect of daclizumab, tacrolimus and mycophenolate mofetil in racial minority first renal transplant recipients. Transplantation Proceedings. 34(5). 1617–1618. 13 indexed citations

16.

Burke, George W., Gaetano Ciancio, Rodolfo Alejandro, et al.. (1998). Use of Tacrolimus and Mycophenolate Mofetil For Pancreas–Kidney Transplantation With or Without OKT3 Induction. Transplantation Proceedings. 30(4). 1544–1545. 30 indexed citations

17.

Ciancio, Gaetano, et al.. (1997). The use of tacrolimus as induction and maintenance immunosuppression in renal cadaveric transplant recipients over the age of 60. Clinical Transplantation. 11(5pt2). 497–499. 15 indexed citations

18.

Roth, David, Ronald D. Smith, Gerald Schulman, et al.. (1994). Effects of Recombinant Human Erythropoietin on Renal Function in Chronic Renal Failure Predialysis Patients. American Journal of Kidney Diseases. 24(5). 777–784. 133 indexed citations

19.

Silva, Marcelo, et al.. (1991). Hepatic dysfunction accompanying acute cocaine intoxication. Journal of Hepatology. 12(3). 312–315. 65 indexed citations

20.

Roth, David, Laphalle Fuller, Victoriano Pardo, et al.. (1985). T CELL LINES AND CLONES PREFERENTIALLY RECOGNIZING KIDNEY-ASSOCIATED ANTIGENS IN END-STAGE RENAL DISEASE. Transplantation. 40(6). 686–693. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact